Full Text
Additional Investments, Added Value, Real World Evidence and Additional Clinical Benefit in the Context of Subgroups of Special Interest

Abstract

Authors

S. Walzer B. Holbein

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×